$OKUR 3 SEC Filings

Filed On	Filing
07 Apr 2026	Form 3: Ai Biotechnology Llc, 10% owner and 3 others Holds 3,998,332 shares of Class A Common Stock
01 Apr 2026	Form 3: Ratcliffe Liam, Director No securities owned
27 May 2025	Form 3: Acorn Bioventures 2, L.p., 10% owner and 1 other Holds 1,129,730 shares of Common Stock
15 Oct 2024	Form 3: Cormorant Asset Management, Lp, 10% owner and 5 others Holds 1,837,739 shares of Class A Common Stock
09 Oct 2024	Form 3: Acorn BIOVENTURES, L.p., 10% owner and 2 others Holds 1,439,674 shares of Class A Common Stock
08 Oct 2024	Form 3: Saccomano Nicholas A, Director No securities owned
08 Oct 2024	Form 3: Phillips Andrew John, Director No securities owned
08 Oct 2024	Form 3: Manke Isaac, Director No securities owned
08 Oct 2024	Form 3: Leverone Jason A., Chief Financial Officer No securities owned
08 Oct 2024	Form 3: Jansen Valerie Malyvanh, Director No securities owned
08 Oct 2024	Form 3: Hartley Dylan, Chief Scientific Officer No securities owned
08 Oct 2024	Form 3: Carruthers R Michael, Director No securities owned
08 Oct 2024	Form 3: Agresta Samuel, Chief Medical Officer No securities owned
16 May 2024	Form 3: Leonard Braden Michael, 10% owner Holds 2,672,194 shares of Common Stock
02 Aug 2022	Form 3: Blunt Roshawn A., Director No securities owned
05 Apr 2022	Form 3: Lam Jennifer, VP of Finance & Administration Holds 15,000 shares of Common Stock
24 Jan 2022	Form 3: Hoelscher Paul W., Director No securities owned
14 Oct 2021	Form 3: Hall Ashley, Chief Development Officer No securities owned
08 Apr 2021	Form 3: Novo Holdings A/S, 10% owner
08 Apr 2021	Form 3: Mathers Edward T, Director No securities owned

Comments